This Small-Cap Vaccine Company Offers 14.5% Upisde, Vetr Crowd Says By: Benzinga via Benzinga August 24, 2016 at 14:48 PM EDT Shares of small cap clinical-stage vaccine company Novavax, Inc. (NASDAQ: NVAX) have lost more than 14.5 percent since the beginning ... Read More >> Related Stocks: Novavax Inc